COMMUNIQUÉS West-GlobeNewswire

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds
29/10/2025
PHOENIX, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. , (Nasdaq: CELZ) (the “Company”), a clinical-stage biotechnology company pioneering regenerative immunotherapy, today announced that [...]
Grâce à l’intégration de l’IA, mediCAD® 8 transforme la planification préopératoire en orthopédie et traumatologie
29/10/2025
LANDSHUT, Allemagne, 29 oct. 2025 (GLOBE NEWSWIRE) -- La dernière version de mediCAD® 8 publiée par mediCAD Hectec GmbH marque une nouvelle ère dans la planification intelligente en orthopédie et traumatologie. En [...]
Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients
29/10/2025
October 29, 2025 3-Year data from the largest global trial to date using Class I, Level A iFR in heart attack patients shows treating additional stenoses in the same procedure showed no significant difference in major [...]
CMR Surgical Adopts NVIDIA IGX THOR for AI-Powered, Next Generation Surgical Robotics
29/10/2025
CMR Surgical Adopts NVIDIA IGX THOR for AI-Powered, Next Generation Surgical Robotics ● Testing to focus on the potential to deliver real-time, AI-powered insights that improve patient outcomes and support continuous [...]
Fangzhou and Fosun Pharma Forge Strategic Alliance to Deliver AI-Powered Psoriasis Management
29/10/2025
SHANGHAI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leader in AI-driven Internet healthcare solutions, and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun [...]
Bio Usawa Takes Strategic Step into Europe with New Subsidiary in Frankfurt, Germany
29/10/2025
KIGALI, Rwanda and FRANKFURT, Germany and SAN FRANCISCO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Bio Usawa Biotechnology Ltd (Rwanda) proudly announces the establishment of its new European subsidiary, Bio Usawa Biotech [...]
Addex Increases Issued Share Capital to Create Treasury Shares
29/10/2025
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, October 29, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel [...]
Roche receives CE mark for novel automated high-throughput Elecsys Dengue Ag test to diagnose dengue
29/10/2025
New dengue antigen test delivers high clinical sensitivity and specificity, as well as inclusivity for all four dengue virus serotypes, helps clinicians confidently distinguish dengue from other acute fever-causing [...]
14-year-old Combines Origami and Physics to Engineer Foldable Structures for Disaster Relief Shelters; Wins $25,000 Top Award at Thermo Fisher Scientific Junior Innovators Challenge
29/10/2025
Young innovators recognized with $100K for STEM research advancing science and tackling global challenges WASHINGTON, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Thermo Fisher Scientific and Society for Science today announced [...]
Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025
28/10/2025
LEXINGTON, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to [...]
GENFIT annonce des avancées dans ses programmes ACLF lors du congrès AASLD The Liver Meeting® 2025
28/10/2025
Plusieurs posters et présentations avec de nouvelles données relatives à trois de nos programmes dans l’ACLF, dont des données de G1090N dans des modèles précliniques, de nouvelles données en vie réelle, et des données [...]
GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting® 2025
28/10/2025
Several posters and presentations featuring new data on three ACLF programs, including G1090N (NTZ reformulation) disease model data, new real-world data and biomarker insights in cirrhosis New Iqirvo® PBC and PSC data [...]
SonderCare Launches Impulse Essential 39” Residential Comfort Bed, Expanding Affordable Luxury Homecare Options in the United States
28/10/2025
Introducing a new standard in entry-level homecare beds — SonderCare’s Impulse Essential delivers premium comfort, safety, and design at an accessible price, now available exclusively in the United States. O'Fallon, MO [...]
Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
28/10/2025
MINNEAPOLIS and BRISBANE, Australia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ( Anteris or the Company ) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, [...]
La Croix-Rouge canadienne met sur pied un fonds de secours pour les personnes touchées par l’ouragan Melissa
28/10/2025
OTTAWA, 28 oct. 2025 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne lance un appel aux dons au profit du Fonds de secours : Ouragan Melissa pour venir en aide aux personnes touchées par le passage de l’ouragan dans les [...]
Canadian Red Cross opens appeal to help people impacted by Hurricane Melissa
28/10/2025
OTTAWA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the Hurricane Melissa Appeal to help those impacted by the hurricane in the Caribbean. The Red Cross is working to get help to people in [...]
Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy
28/10/2025
CHARLOTTE, N.C., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced the closing of its previously announced best [...]
Spectral AI Schedules 2025 Third Quarter Financial Results and Conference Call
28/10/2025
DALLAS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]
Kura Oncology to Report Third Quarter 2025 Financial Results
28/10/2025
SAN DIEGO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today [...]

Pages